A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. (Q40459544)
Jump to navigation
Jump to search
scientific article published on February 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. |
scientific article published on February 2007 |
Statements
1 reference
A phase II, double-blind, placebo-controlled, ascending-dose study of Eritoran (E5564), a lipid A antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypass. (English)
1 reference
Jerrold H Levy
1 reference
Elliott Bennett-Guerrero
1 reference
Hilary P Grocott
1 reference
Kevin A Stierer
1 reference
Charles W Hogue
1 reference
Albert T Cheung
1 reference
Mark F Newman
1 reference
Alison A Carter
1 reference
Daniel P Rossignol
1 reference
Charles D Collard
1 reference
1 February 2007
1 reference
1 reference
1 reference
Identifiers
1 reference